CJC-1295 with DAC and HGH Interaction
CJC-1295 with DAC and HGH have a potentially harmful interaction with 95% confidence. Defeats purpose and may suppress natural production. Both compounds affect the gi tract and pituitary, so monitoring these systems is recommended.
Compound Profiles
CJC-1295 with DAC
Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release
DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..
View full profileHGH
Human Growth Hormone | Somatropin
Binds to GH receptors on target tissues, triggering JAK2-STAT5 signaling pathway. Direct effects include lipolysis, protein synthesis, and metabolic regulation.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take CJC-1295 with DAC with HGH?
Combining CJC-1295 with DAC with HGH is not recommended. Defeats purpose and may suppress natural production.
Is CJC-1295 with DAC and HGH safe together?
This combination carries significant risk. Defeats purpose and may suppress natural production. Consult a healthcare professional before combining.
What are the interactions between CJC-1295 with DAC and HGH?
Defeats purpose and may suppress natural production. This assessment has 95% confidence and is based on documented research data.
How should I time CJC-1295 with DAC and HGH?
CJC-1295 with DAC has a half-life of 6-8 days and HGH has a half-life of 3-4 hours (SC), 20-30 minutes (IV). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.